EORTC Headquarters Institutional Review Board (IRB)

The Institutional Review Board (IRB) of the EORTC Headquarters is responsible for safeguarding the rights and welfare of subjects participating in clinical trials supported by the Headquarters. In particular, the IRB is responsible for protecting the privacy and confidentiality of the individuals’ data. The IRB is responsible for the validation of the document templates for informed consent and patient information sheets. All institutions and investigators submitting data to the Headquarters agree to abide by the decisions of the IRB regarding data collection, transfer, storage, release, retention, and disposition, as
these pertain to individual patient privacy and confidentiality. The IRB also reviews potential conflicts of interest reported to the Headquarters. All electronic and computer programmes/software and procedures are evaluated annually in order to comply with the international requirements for patient data protection.

In addition, the EORTC IRB oversees the clinical trials performed with the US cooperative groups / national cancer institutes under the Federal Wide Agreement (FWA).


Members

Chair D. Lacombe, Brussels (BE)

F. Crawley, Leuven (BE)
H. Nys, Leuven (BE)
A. Negrouk, Brussels (BE)
J. Otten, Brussels (BE)
J.-C. Pector, Brussels (BE)
P. Ruyskart, Brussels (BE)
S. Suciu, Brussels (BE)
R. Sylvester, Brussels (BE)


Last updated 27-08-2009